These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 21465550

  • 1. Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype.
    Ormazabal A, Serrano M, Garcia-Cazorla A, Campistol J, Artuch R, Castro de Castro P, Barredo-Valderrama E, Armstrong J, Toma C, Cormand B.
    Mov Disord; 2011 Jul; 26(8):1558-60. PubMed ID: 21465550
    [No Abstract] [Full Text] [Related]

  • 2. Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections.
    Diepold K, Schütz B, Rostasy K, Wilken B, Hougaard P, Güttler F, Romstad A, Birk Møller L.
    Mov Disord; 2005 Jun; 20(6):764-7. PubMed ID: 15747353
    [Abstract] [Full Text] [Related]

  • 3. Movement disorders: advances in 2015.
    Hattori N.
    Lancet Neurol; 2016 Jan; 15(1):8-9. PubMed ID: 26700896
    [No Abstract] [Full Text] [Related]

  • 4. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
    Willemsen MA, Verbeek MM, Kamsteeg EJ, de Rijk-van Andel JF, Aeby A, Blau N, Burlina A, Donati MA, Geurtz B, Grattan-Smith PJ, Haeussler M, Hoffmann GF, Jung H, de Klerk JB, van der Knaap MS, Kok F, Leuzzi V, de Lonlay P, Megarbane A, Monaghan H, Renier WO, Rondot P, Ryan MM, Seeger J, Smeitink JA, Steenbergen-Spanjers GC, Wassmer E, Weschke B, Wijburg FA, Wilcken B, Zafeiriou DI, Wevers RA.
    Brain; 2010 Jun; 133(Pt 6):1810-22. PubMed ID: 20430833
    [Abstract] [Full Text] [Related]

  • 5. Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease.
    Hutton JT, Morris JL, Bush DF, Smith ME, Liss CL, Reines S.
    Neurology; 1989 Nov; 39(11 Suppl 2):67-72; discussion 72-3. PubMed ID: 2685652
    [Abstract] [Full Text] [Related]

  • 6. Levodopa-responsive aromatic L-amino acid decarboxylase deficiency.
    Chang YT, Sharma R, Marsh JL, McPherson JD, Bedell JA, Knust A, Bräutigam C, Hoffmann GF, Hyland K.
    Ann Neurol; 2004 Mar; 55(3):435-8. PubMed ID: 14991824
    [Abstract] [Full Text] [Related]

  • 7. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
    Med Lett Drugs Ther; 2005 Jan 31; 47(1201):12. PubMed ID: 15706700
    [Abstract] [Full Text] [Related]

  • 8. Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.
    Fernandez HH, Odin P.
    Curr Med Res Opin; 2011 May 31; 27(5):907-19. PubMed ID: 21351823
    [Abstract] [Full Text] [Related]

  • 9. Tyrosine hydroxylase deficiency presenting with a biphasic clinical course.
    Giovanniello T, Leuzzi V, Carducci C, Carducci C, Sabato ML, Artiola C, Santagata S, Pozzessere S, Antonozzi I.
    Neuropediatrics; 2007 Aug 31; 38(4):213-5. PubMed ID: 18058633
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sinemet CR in Parkinson's disease.
    Pfeiffer RF, Wilken KE, Glaeske CS, Hofman R.
    Nebr Med J; 1991 Jan 31; 76(1):8-10. PubMed ID: 1997878
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Infantile hypokinetic-hypotonic syndrome due to two novel mutations of the tyrosine hydroxylase gene.
    Doummar D, Clot F, Vidailhet M, Afenjar A, Durr A, Brice A, Mignot C, Guet A, de Villemeur TB, Rodriguez D.
    Mov Disord; 2009 Apr 30; 24(6):943-5. PubMed ID: 19224593
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
    Fleming SM, Delville Y, Schallert T.
    Behav Brain Res; 2005 Jan 30; 156(2):201-13. PubMed ID: 15582106
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
    Jankovic J, Caskey TC, Stout JT, Butler IJ.
    Ann Neurol; 1988 May 30; 23(5):466-9. PubMed ID: 2455472
    [Abstract] [Full Text] [Related]

  • 18. [Drug therapy of Parkinson's disease].
    Zhou XD.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug 30; 18(4):193-6. PubMed ID: 4075905
    [No Abstract] [Full Text] [Related]

  • 19. Carbidopa-levodopa therapy for movement disorders.
    Sohn DG, Hoerning E, Kaplan PE.
    Arch Phys Med Rehabil; 1987 Oct 30; 68(10):745-6. PubMed ID: 3662785
    [No Abstract] [Full Text] [Related]

  • 20. Intrafamilial variability in Machado-Joseph disease.
    Subramony SH, Currier RD.
    Mov Disord; 1996 Nov 30; 11(6):741-3. PubMed ID: 8914106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.